Healthcare -
Biotechnology - NASDAQ - US
$ 5.25
8.25 %
$ 111 M
Market Cap
-0.96
P/E
Price Target
Average
1150.79%
Revenue Forecast
Estimate
--14.82%
EBIT
Estimate
29.01%
Net Income
Estimate
--4.81%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Enanta Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for ENTA of $65.7 , with forecasts ranging from
a
low of
$54 to a high of $87 .
ENTA Lowest Price Target
Wall Street Target
54 USD
928.57%
ENTA Average Price Target
Wall Street Target
65.7 USD
1150.79%
ENTA Highest Price Target
Wall Street Target
87 USD
1557.14%
REVENUE FORECAST
Revenue Forecast Chart ENTA
EBIT FORECAST
EBIT Forecast Chart ENTA
NET INCOME FORECAST
Net Income Chart ENTA